K F McClure - JoVE Visualize

Showing results (1-10 of 5) with videos related to

Pageof 1

Sort By:

Bioorganic & Medicinal Chemistry Letters|January 1, 1999

Alkylation of succinates: synthesis of Ro 32-3555K F McClure, M Z Axt

Science (New York, N.Y.)|May 28, 1993

A strategy for the solid-phase synthesis of oligosaccharidesS J Danishefsky, K F McClure, J T Randolph, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 30, 1996

Template-nucleated alanine-lysine helices are stabilized by position-dependent interactions between the lysine side chain and the helix barrelK Groebke, P Renold, K Y Tsang, et al.

Circulation|June 15, 1999

Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in miceL E Rohde, A Ducharme, L H Arroyo, et al.

British Journal of Pharmacology|January 20, 2016

Pharmacological characterization of the first in class clinical candidate PF-05190457: a selective ghrelin receptor competitive antagonist with inverse agonism that increases vagal afferent firing and glucose-dependent insulin secretion ex vivoJ Kong, J Chuddy, I A Stock, et al.

Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:

Pageof 1

Bioorganic & Medicinal Chemistry Letters|January 1, 1999

Alkylation of succinates: synthesis of Ro 32-3555K F McClure, M Z Axt

Science (New York, N.Y.)|May 28, 1993

A strategy for the solid-phase synthesis of oligosaccharidesS J Danishefsky, K F McClure, J T Randolph, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 30, 1996

Template-nucleated alanine-lysine helices are stabilized by position-dependent interactions between the lysine side chain and the helix barrelK Groebke, P Renold, K Y Tsang, et al.

Circulation|June 15, 1999

Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in miceL E Rohde, A Ducharme, L H Arroyo, et al.

British Journal of Pharmacology|January 20, 2016

Pharmacological characterization of the first in class clinical candidate PF-05190457: a selective ghrelin receptor competitive antagonist with inverse agonism that increases vagal afferent firing and glucose-dependent insulin secretion ex vivoJ Kong, J Chuddy, I A Stock, et al.

Pageof 1